$TNGX
This Pancreatic Cancer Gem is giving another technical Setup
"92% Response Rate in pancreatic Cancer and Runup into Phase 3 Data"
We stopped out last time.
For In Depth Analysis check
@tenet_research
Target remains 30/34+ on this triple bottom gap bounce
@Pharmdca